EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Systemic methotrexate (MTX) in early pregnancy: a retrospective study of a tertiary maternity hospital

Ahmed Lutfi, Deirdre Hayes-Ryan, Elmarie Cottrell, Richard A Greene

Irish Journal of Medical Science (1971 -) · 2024-10 · 193 (5) · 2389-2395

DOI: 10.1007/s11845-024-03748-9 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Irish Journal of Medical Science (1971 -), 2024-10. Verfasst von Ahmed Lutfi und 3 weiteren Autor:innen. Beteiligte Einrichtung: Department of Obstetrics and Gynaecology, Cork University Maternity Hospital, Cork, Ireland. ahmed.lutfi@hse.ie. Hauptthemen laut MEDLINE: Methotrexate, Abortifacient Agents, Nonsteroidal, Tertiary Care Centers, Pregnancy, Ectopic. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 31 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: University College Cork.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

Methotrexate (MTX) is used in clinical practice as a medical treatment option in patients with early pregnancy complications like ectopic pregnancy.

Aims

To review systemic MTX therapy use in the first trimester of pregnancy in our hospital and to examine subsequent clinical outcomes.

Methods

Retrospective review of all women treated with systemic MTX in early pregnancy identified from electronic prescription records from 1 January 2018 to 31 December 2020 at Cork University Maternity Hospital, Ireland. Relevant data was transcribed from electronic health records.

Results

Indications for treatment were tubal ectopic pregnancy (70%, n = 51), persistent pregnancy of unknown location (22%, n = 16) and caesarean scar pregnancy (7%, n = 5). Treatment was successful in 88% ( n = 44) of tubal ectopic pregnancies with 73% ( n = 37) and 14% ( n = 7) of women receiving a single dose and repeated doses, respectively. Only 8% ( n = 4) of tubal ectopic pregnancies required emergency surgery for subsequent tubal rupture. In 93% ( n = 15) of cases of persistent pregnancy of unknown location, treatment was successful with one patient requiring uterine evacuation. Women with caesarean scar pregnancy were treated with combined MTX and uterine evacuation without complication.

Conclusions

The efficacy of medical treatment with systemic MTX for confirmed tubal ectopic pregnancy in our hospital is in line with national and international standards. Careful consideration should be given to treating caesarean scar pregnancy and persistent pregnancy of unknown location with systemic MTX. Systemic MTX use guided by clinicians specialised in early pregnancy complications and safe medication practices may improve treatment success and reduce adverse events.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

MethotrexateAbortifacient Agents, NonsteroidalTertiary Care CentersPregnancy, EctopicHospitals, MaternityHumansFemalePregnancyRetrospective StudiesAdultPregnancy Trimester, FirstIreland

Stichwörter der Autor:innen

Early pregnancyEctopic pregnancyMethotrexatePregnancy of unknown location

Substanzen

MethotrexateAbortifacient Agents, Nonsteroidal

Autor:innen und Institutionen

  • Department of Obstetrics and Gynaecology, Cork University Maternity Hospital, Cork, Ireland. ahmed.lutfi@hse.ie.
  • Department of Obstetrics and Gynaecology, Cork University Maternity Hospital, Cork, Ireland.
  • Pregnancy Loss Research Group, Department of Obstetrics and Gynaecology, University College Cork, Cork, Ireland.
  • Department of Obstetrics and Gynaecology, National Perinatal Epidemiology Centre, University College Cork, Cork, Ireland.
  • Department of Pharmacy, Cork University Hospital, Cork, Ireland.

Förderung

  • University College Cork

Zitieren

APA

Lutfi, A., Hayes-Ryan, D., Cottrell, E., & Greene, R. A. (2024). Systemic methotrexate (MTX) in early pregnancy: a retrospective study of a tertiary maternity hospital. Irish Journal of Medical Science (1971 -). https://doi.org/10.1007/s11845-024-03748-9

Vancouver

Lutfi A, Hayes-Ryan D, Cottrell E, Greene RA. Systemic methotrexate (MTX) in early pregnancy: a retrospective study of a tertiary maternity hospital. Irish Journal of Medical Science (1971 -). 2024. doi:10.1007/s11845-024-03748-9

BibTeX
@article{Lutfi2024,
  author = {Lutfi, Ahmed and Hayes-Ryan, Deirdre and Cottrell, Elmarie and Greene, Richard A},
  title = {Systemic methotrexate (MTX) in early pregnancy: a retrospective study of a tertiary maternity hospital},
  journal = {Irish Journal of Medical Science (1971 -)},
  year = {2024},
  doi = {10.1007/s11845-024-03748-9}
}
Kostenlos starten →